Cell Cycle & Cell Division

Somatostatin (SST) is a peptide hormone that binds to somatostatin receptors (SSTR1–5). These receptors inhibit cell growth, among other cellular functions (1). Elevated SSTR2 expression inhibits cell growth by inducing apoptosis and cell cycle arrest and reducing epidermal growth factor receptor (EGFR) signaling (2).

The BTG/Tob protein family, which consists of six members, including TOB1, TOB2, BTG1, BTG2/PC3/TIS21, BTG3/ANA and BTG4/PC3B, are negative regulators of the cell cycle that help to prevent uncontrolled cell proliferation (3).

TOB1 expression suppresses the transcription of positive cell cycle regulators, including IL2, IL4, IFNg, cyclin E and cyclin A, inhibiting cell proliferation (4). BTG/TOB proteins also inhibit cell proliferation by potentially enhancing deadenylation. TOB2 promotes deadenylation by recruiting Caf1 deadenylase to the mRNA poly(A) tail. This recruitment occurs through the interaction of TOB2 with Caf1 and poly(A)-binding protein (PABP). BTG1 is another antiproliferative mediator whose expression peaks in the G0/G1 phases of the cell cycle and drops as cells move through G1. BTG2 negatively regulates the cell cycle checkpoint from the G1 to S phase by suppressing cyclin D1 promoter activity. BTG3 binds to transcription factor E2F1 to regulate cell proliferation and the G2 checkpoint (5). BTG4 induces G1 and G2 arrest in the cell cycle by targeting the CD1/CDK4 pathway, the cyclin E pathway or transcription factors PRMT1 and CAF-1 (6).

Copytext, Body 1 (18px) Futura Book Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

G1 is the phase where the cell prepares to divide. It then moves into the S phase, where the cell creates additional copies of the DNA (8). In the G1 phase, growth-dependent CDK activity stimulates DNA replication and triggers the transition from G1 to the S phase. CDK activation also sets off a positive feedback loop that leads to increased CDK activity, initiating genome-wide transcriptional changes to ensure cell division (9).

The G2 checkpoint maintains genomic stability by preventing DNA-damaged cells from entering mitosis. This mechanism stops the proliferation of damaged cells and allows for DNA repair (10).

The serine/threonine kinase complex CDK1/Cyclin B is the principal regulator of the transition from G2 to M. CDK1 levels remain constant throughout the cell cycle, while Cyclin B levels peak during early mitosis and drop to their lowest at the end of M phase. Cyclin B levels are regulated at the transcriptional level through transcription factors NF-Y, FOXM1 and B-MYB and by proteolysis through the E3 ubiquitin ligase APC. Activated Cdk1-Cyclin B phosphorylates mitotic substrates, including Wee1/Myt1 and Cdc25, to regulate G2 to M transition (11).

Cyclins are a family of regulatory proteins that play a crucial role in controlling the progression of cells through the cell cycle. They function as regulatory subunits of cyclin-dependent kinases (CDKs), which are enzymes that drive regulate cell cycle progression by phosphorylating and activating specific target substrates. One critical target, for example, is the retinoblastoma (Rb) protein, which, when phosphorylated, allows the cell to progress from the G1 phase to the S phase of the cell cycle. (12)

In mammals, there are five major classes of cyclins involved in cell cycle regulation: cyclins A, B, C, D and E. D-type cyclins (cyclin D1, D2 and D3) are crucial during the G1 phase, where they form complexes with CDK4 and CDK6 to drive the cell past the G1 checkpoint. Cyclin E, in association with CDK2, facilitates the transition from G1 to S phase, initiating DNA replication. Cyclin A binds to CDK2 during the S phase and later to CDK1, playing pivotal roles in both S phase progression and the G2/M transition. Cyclin B, in a complex with CDK1, is essential for the initiation of mitosis. Cyclin C, although less well-characterized, is known to play a role in regulating the G1 phase in association with CDK3. (12)

The expression levels of cyclins vary throughout the cell cycle, with each type appearing at specific stages to activate the corresponding CDKs. This regulated expression ensures that the cell cycle progresses in a controlled manner and prevents uncontrolled cell division, which could lead to cancer.

High mobility group box 1 (HMGB1) is a non-histone nuclear protein that plays many roles depending on its location within the cell. In the nucleus, HMGB1 interacts with DNA and histones to maintain the structure and function of chromosomes and regulate transcription, DNA repair, genome stability and other cellular processes. In the cytoplasm, it promotes autophagy by binding to the BECN1 protein (13). In the context of the cell cycle, HMGB1 can interact with p53 to modulate its transcriptional activity, thereby influencing cell cycle arrest and apoptosis (14).

Copytext, Body 1 (18px) Futura Book Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

CHK proteins are activated in response to DNA damage. Checkpoint kinase 1 (Chk1) mediates the G1/S transition, S phase, mitotic entry and spindle checkpoint in the M phase. On the other hand, checkpoint kinase 2 (CHK2) activity arrests the cell cycle at G1/S and G2/M (17, 18). CHK proteins phosphorylate and inhibit Cdc25 phosphatases, preventing CDC2 activation and thereby halting cell cycle progression. CHK2 and CHK1 also regulate the cell cycle by phosphorylating P53 and upregulating P212, further inhibiting cell cycle progression (19).

Copytext, Body 1 (18px) Futura Book Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.